Genetic Predisposition to Drug-Induced Liver Injury.
Candidate gene studies
Drug metabolism
Genome-wide association studies
Human leukocyte antigen
Pharmacogenetics
Pharmacogenomics
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
27
7
2021
Statut:
ppublish
Résumé
Identification of genetic predisposition to drug-induced liver injury (DILI) is of paramount importance. Early candidate gene studies have identified various polymorphisms in drug-metabolizing genes that infer increased DILI susceptibility. Few of these have been confirmed in more recent genome-wide association studies, which have identified several specific human leukocyte antigen (HLA) alleles. The low incidence rate of DILI, however, leads to a low positive predictive value for currently identified genetic variations, making them unsuitable for pre-prescription screening. HLA screening incorporated into clinical practice can aid the diagnostic process resulting in enhanced diagnostic accuracy and confidence.
Identifiants
pubmed: 31753244
pii: S1089-3261(19)30053-4
doi: 10.1016/j.cld.2019.08.003
pii:
doi:
Substances chimiques
HLA Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-23Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.